Perturbations in O-linked β-N-acetylglucosamine protein modification cause severe defects in mitotic progression and cytokinesis

被引:234
作者
Slawson, C
Zachara, NE
Vosseller, K
Cheung, WD
Lane, MD
Hart, GW
机构
[1] Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA
[2] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA
关键词
D O I
10.1074/jbc.M503396200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The dynamic modification of nuclear and cytoplasmic proteins with O-linked beta-N-acetylglucosamine (O-GlcNAc) is a regulatory post-translational modification that is rapidly responsive to morphogens, hormones, nutrients, and cellular stress. Here we show that O-GlcNAc is an important regulator of the cell cycle. Increased O-GlcNAc (pharmacologically or genetically) results in growth defects linked to delays in G(2)/M progression, altered mitotic phosphorylation, and cyclin expression. Overexpression of O-GlcNAcase, the enzyme that removes O-GlcNAc, induces amitotic exit phenotype accompanied by a delay in mitotic phosphorylation, altered cyclin expression, and pronounced disruption in nuclear organization. Overexpression of the O-GlcNAc transferase, the enzyme that adds O-GlcNAc, results in a polyploid phenotype with faulty cytokinesis. Notably, O-GlcNAc transferase is concentrated at the mitotic spindle and midbody at M phase. These data suggest that dynamic O-GlcNAc processing is a pivotal regulatory component of the cell cycle, controlling cell cycle progression by regulating mitotic phosphorylation, cyclin expression, and cell division.
引用
收藏
页码:32944 / 32956
页数:13
相关论文
共 65 条
[1]   Regulation of the retinoblastoma tumor suppressor protein by cyclin/cdks [J].
Adams, PD .
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2001, 1471 (03) :M123-M133
[2]   The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine [J].
Arnold, CS ;
Johnson, GVW ;
Cole, RN ;
Dong, DLY ;
Lee, M ;
Hart, GW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :28741-28744
[3]   Characterization of the transcriptional regulator YY1 - The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAF(II)55, or cAMP-responsive element-binding protein (CBP)-binding protein [J].
Austen, M ;
Luscher, B ;
LuscherFirzlaff, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (03) :1709-1717
[4]   It's All in the Timing Linking S Phase to Chromatin Structure and Chromosome Dynamics [J].
Bailis, Julie M. ;
Forsburg, Susan L. .
CELL CYCLE, 2003, 2 (04) :303-306
[5]   Genome-wide survey of protein kinases required for cell cycle progression [J].
Bettencourt-Dias, M ;
Giet, R ;
Sinka, R ;
Mazumdar, A ;
Lock, WG ;
Balloux, F ;
Zafiropoulos, PJ ;
Yamaguchi, S ;
Winter, S ;
Carthew, RW ;
Cooper, M ;
Jones, D ;
Frenz, L ;
Glover, DM .
NATURE, 2004, 432 (7020) :980-987
[6]   Decreased UDP-GlcNAc levels abrogate proliferation control in EMeg32-deficient cells [J].
Boehmelt, G ;
Wakeham, A ;
Elia, A ;
Sasaki, T ;
Plyte, S ;
Potter, J ;
Yang, YJ ;
Tsang, E ;
Ruland, J ;
Iscove, NN ;
Dennis, JW ;
Mak, TW .
EMBO JOURNAL, 2000, 19 (19) :5092-5104
[7]   Alternative O-glycosylation/O-phosphorylation of the murine estrogen receptor β [J].
Cheng, XG ;
Cole, RN ;
Zaia, J ;
Hart, GW .
BIOCHEMISTRY, 2000, 39 (38) :11609-11620
[8]  
CHOU CF, 1993, J BIOL CHEM, V268, P4465
[9]   C-MYC IS GLYCOSYLATED AT THREONINE-58, A KNOWN PHOSPHORYLATION SITE AND A MUTATIONAL HOT-SPOT IN LYMPHOMAS [J].
CHOU, TY ;
HART, GW ;
DANG, CV .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (32) :18961-18965
[10]   Diabetes and the accompanying hyperglycemia impairs cardiomyocyte calcium cycling through increased nuclear O-GlcNAcylation [J].
Clark, RJ ;
McDonough, PM ;
Swanson, E ;
Trost, SU ;
Suzuki, M ;
Fukuda, M ;
Dillmann, WH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) :44230-44237